0001157523-17-001535.txt : 20170511 0001157523-17-001535.hdr.sgml : 20170511 20170511074444 ACCESSION NUMBER: 0001157523-17-001535 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syneron Medical Ltd. CENTRAL INDEX KEY: 0001291361 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80182 FILM NUMBER: 17832539 BUSINESS ADDRESS: BUSINESS PHONE: 972-4-909-6200 MAIL ADDRESS: STREET 1: INDUSTRIAL ZONE STREET 2: P.O.B. 550 CITY: YOKNEAM ILLIT STATE: L3 ZIP: 20692 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Sand Grove Capital Management LLP CENTRAL INDEX KEY: 0001665077 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 4TH FLOOR, 35 DOVER STREET CITY: LONDON STATE: X0 ZIP: W1S 4NQ BUSINESS PHONE: 02037708617 MAIL ADDRESS: STREET 1: 4TH FLOOR, 35 DOVER STREET CITY: LONDON STATE: X0 ZIP: W1S 4NQ SC 13D/A 1 a51557256.htm SYNERON MEDICAL LTD SC 13D/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
 
SYNERON MEDICAL LTD
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
M87245102
(CUSIP Number)
 
Jonathan Groom
4th floor, 35 Dover Street
London
W1S 4NQ
+44 (0) 203 770 8613
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
10 May 2017
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
         
CUSIP No. M87245102
 
13D
 
Page 2 of 4 Pages
 
     
1.
 
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 SAND GROVE CAPITAL MANAGEMENT LLP
2.
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ☐
(b) ☒
3.
 
SEC USE ONLY
4.
 
SOURCE OF FUNDS (see instructions)

 OO
5.
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐
6.
 
CITIZENSHIP OR PLACE OF ORGANIZATION

 United Kingdom
 
NUMBER OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7.
 
SOLE VOTING POWER

 1,501,205
8.
 
SHARED VOTING POWER
9.
 
SOLE DISPOSITIVE POWER

 1,501,205
10.
 
SHARED DISPOSITIVE POWER
 
11.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,501,205
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions) ☐
13.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 4.3%
14.
 
TYPE OF REPORTING PERSON (see instructions)

 PN
 

         
CUSIP No. M87245102
 
13D
 
Page 3 of 4 Pages
 
 
  
 
  
 
        
Item 1. Security and Issuer.
 
Item 2. Identity and Background.
 
Item 3. Source or Amount of Funds or Other Consideration.
 
Item 4. Purpose of Transaction.
 
Item 5. Interest in Securities of the Issuer.
 
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
Item 7. Material to Be Filed as Exhibits.
 
 
 
         
CUSIP No. M87245102
 
13D
 
Page 4 of 4 Pages
 
 
  
 
  
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
 
COMPANY NAME
 
     
 
Sand Grove Capital Management LLP
 
 
 Insert Name  
     
 
Daniel McLachlan – Operations Analyst
 
 
Insert Title
 
     
 
11 May 2017
  
 
 Insert Date